Testing the Addition of an Anti-Cancer Drug, Triapine, to the Usual Radiation Therapy for Recurrent Glioblastoma or Astrocytoma
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
University of Florida
Nuvation Bio Inc.
Essen Biotech
Dana-Farber Cancer Institute
Alliance for Clinical Trials in Oncology
Barbara Ann Karmanos Cancer Institute
City of Hope Medical Center
Eisai Inc.
University of California, San Francisco
University of California, San Francisco
St. Jude Children's Research Hospital
Eastern Cooperative Oncology Group
Northwell Health
Samus Therapeutics, Inc.
Northwestern University
Virginia Commonwealth University
M.D. Anderson Cancer Center
AbbVie
City of Hope Medical Center
University of Texas Southwestern Medical Center
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Masonic Cancer Center, University of Minnesota
Fred Hutchinson Cancer Center
OHSU Knight Cancer Institute
OHSU Knight Cancer Institute
University of Louisville
Case Comprehensive Cancer Center
Fred Hutchinson Cancer Center
Rutgers, The State University of New Jersey
Duke University
Jonsson Comprehensive Cancer Center
Barbara Ann Karmanos Cancer Institute
Duke University
City of Hope Medical Center
National Cancer Institute (NCI)
Indiana University
University of Minnesota
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
INSYS Therapeutics Inc
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Novartis
University of Kentucky
National Cancer Institute (NCI)